Quantbot Technologies’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
Other funds holding CTNM
Quantbot Technologies's CTNM Position: Q3 2026 in Review
Quantbot Technologies opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 26,976 shares worth $362K. The stake represents 0.01% of the portfolio and ranks #1130 among its holdings.
118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.
- Quantbot Technologies held 26,976 shares of Contineum Therapeutics worth $362K as of Q3 2026.
- Contineum Therapeutics was a new Quantbot Technologies position in Q3 2026.
- Contineum Therapeutics made up 0.01% of Quantbot Technologies's portfolio in Q3 2026, its #1130 holding.
- 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.
Based on Quantbot Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.